X-100670962-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000373004.5(SRPX2):c.1373G>A(p.Arg458Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,208,481 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 78 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000373004.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX2 | NM_014467.3 | c.1373G>A | p.Arg458Gln | missense_variant | 11/11 | ENST00000373004.5 | NP_055282.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX2 | ENST00000373004.5 | c.1373G>A | p.Arg458Gln | missense_variant | 11/11 | 1 | NM_014467.3 | ENSP00000362095 | P1 | |
SRPX2 | ENST00000640282.1 | c.*108G>A | 3_prime_UTR_variant | 3/3 | 5 | ENSP00000491188 | ||||
SRPX2 | ENST00000638920.1 | n.1376G>A | non_coding_transcript_exon_variant | 10/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00121 AC: 135AN: 111813Hom.: 0 Cov.: 22 AF XY: 0.000912 AC XY: 31AN XY: 33997
GnomAD3 exomes AF: 0.000340 AC: 61AN: 179344Hom.: 0 AF XY: 0.000188 AC XY: 12AN XY: 63992
GnomAD4 exome AF: 0.000150 AC: 164AN: 1096615Hom.: 0 Cov.: 31 AF XY: 0.000130 AC XY: 47AN XY: 362021
GnomAD4 genome AF: 0.00122 AC: 136AN: 111866Hom.: 0 Cov.: 22 AF XY: 0.000910 AC XY: 31AN XY: 34060
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 08, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 21, 2017 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 05, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | - - |
SRPX2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 07, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at